Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Albemarle stock downgraded by Scotiabank, price target cut

EditorAhmed Abdulazez Abdulkadir
Published 22/05/2024, 09:12 pm
ALB
-

On Wednesday, Scotiabank adjusted its stance on Albemarle Corporation (NYSE:ALB), a leading chemical company, shifting its rating from "Sector Outperform" to "Sector Perform." The firm also revised the price target for Albemarle's stock, lowering it to $135.00 from the previous target of $150.00.

The revision by Scotiabank comes after the firm reevaluated its financial model for Albemarle, taking into account the company's new definition of Adjusted EBITDA. This redefinition now incorporates the company's proportional share of income tax expense at its Winfield operations. The impact of this change was significant, as it led to an increase in EBITDA for the year 2023 by $0.8 billion, raising it to $3.6 billion from the earlier $2.8 billion.

Scotiabank's updated model projects Albemarle's EBITDA for the year 2025 to be $2.2 billion, which is comparable to an operating EBITDA of $1.7 billion. This projection is lower than the consensus EBITDA estimate of $1.9 billion by other analysts, some of whom have adapted their models to the new definition, while others have not.

Additionally, Scotiabank has modified its cash flow outlook for Albemarle, anticipating deeply negative free cash flow (FCF) in 2024, followed by moderately negative FCF in 2025 and 2026. The analyst noted that these forecasts could worsen if more conservative mid-term price assumptions are applied, moving away from the current $20/kg estimate.

The report concluded by mentioning that several enhancements and corrections were made to the model, including updates on the timing and progression of how projects are expected to ramp up. This comprehensive update to the financial model reflects the latest available data and trends affecting Albemarle's performance and outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.